FDAnews Device Daily Bulletin

Seegene Debuts Automated Development for Molecular Testing Devices

Aug. 4, 2016

Seegene has developed a in silico-based solution for automated development of molecular testing devices, the company revealed Wednesday.

The automated solution can reduce assay development time significantly, down to less than a week.

By using an in silico-based development solution, Seegene has found a way to simplify the process of real-time PCR assay development and is looking to expand its use in molecular diagnostics, the company disclosed. — Cynthia Jessup

View today's stories